{"id":"NCT00143507","sponsor":"Institut de Recherches Internationales Servier","briefTitle":"The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction","officialTitle":"Effects of Ivabradine on Cardiovascular Events in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction. A Three-year Randomised Double-blind Placebo-controlled International Multicentre Study.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-12","primaryCompletion":"2008-02","completion":"2008-02","firstPosted":"2005-09-02","resultsPosted":"2015-06-25","lastUpdate":"2018-04-12"},"enrollment":10917,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Coronary Disease","Ventricular Dysfunction, Left"],"interventions":[{"type":"DRUG","name":"Ivabradine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Ivabradine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The aim of this study is to test whether ivabradine is able to reduce cardiovascular events when given to patients with coronary artery disease and impaired heart function.","primaryOutcome":{"measure":"Primary Composite Endpoint","timeFrame":"From the date of randomisation to the date of the first occurrence of the first event, up to 3 years.","effectByArm":[{"arm":"Ivabradine","deltaMin":844,"sd":null},{"arm":"Placebo","deltaMin":832,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.945"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":["18757088"],"seeAlso":["http://clinicaltrials.servier.com/wp-content/uploads/CL3-16257-056_synopsis_report.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":1625,"n":5477},"commonTop":["Cardiac failure","Blood pressure inadequately controlled","Diabetes mellitus inadequate control","Atrial fibrillation","Phosphenes"]}}